Cash Flow Sapporo Clinical Laboratory, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
699.00
597.00
959.00
1,502.00
1,175.00
845.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-323.00
90.00
234.00
-92.00
-246.00
296.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
730.00
1,077.00
1,430.00
1,573.00
837.00
1,255.00
Cash Flow from Investing Activities
-1,240.00
-395.00
-409.00
-610.00
-3,148.00
-2,913.00
Cash Flow from Financing Activities
-525.00
-369.00
-347.00
-332.00
1,943.00
-51.00
Net Cash Inflow / Outflow
-1,035.00
312.00
673.00
629.00
-367.00
-1,709.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Sapporo Clinical Laboratory, Inc.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
699.777
2024.759
-1,325.00
-65.44%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-323.668
-559.716
236.00
42.17%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
730.911
1208.104
-478.00
-39.50%
Cash Flow from Investing Activities
-1240.168
-1814.142
574.00
31.64%
Cash Flow from Financing Activities
-525.743
-283.624
-242.00
-85.37%
Net Cash Inflow / Outflow
-1035
-889.662
-146.00
-16.34%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is -32.17% vs -24.66% in Mar 2024
Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
730.91
1,077.59
-32.17%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
